Delivery Order SPE2DB20D1050-SPE2DB24FH44S
Award Date 1/3/24
Potential Completion Date 1/4/24
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,403.46, is for the delivery of NAFTIFINE HCL 2% CREAM 45GM, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,703.00 firm fixed-price delivery order contract is for the supply of NAFTIFINE HCL 1% CREAM 90GM. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $4,737.94 for the supply of NAFTIFINE HCL 1% CREAM 60GM. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2023. The contract type is Firm Fixed Price, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $1,873.54 for the supply of 4556611118 - Naftifine HCL 1% Cream 60GM. The contract has an ultimate completion date of March 21, 2022 and was awarded on March 18, 2022 under a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Naftifine HCL 1% Cream, a pharmaceutical product, with a ceiling value of $1,048.52 and a period of performance through April 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,319.28 firm fixed price delivery order is for the supply of NAFTIFINE HCL 1% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,738.15 firm fixed-price delivery order is for the supply of 4562275506 - NAFTIFINE HCL 1% CREAM 60GM, with an ultimate completion date of September 25, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,014.57, is for the delivery of a pharmaceutical product, specifically Naftifine HCL 1% Cream 60GM. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAFTIFINE HCL 1% CREAM 60GM, with a ceiling value of $1,166.53 and a period of performance through November 18, 2024. The contract was awarded on November 15, 2024 and is a Firm Fixed Price Delivery Order. This award is not designated with a set-aside. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $1,158.90, is for the supply of Naftifine HCL 1% Cream in 60 gram units. The award has no set-aside designation, indicating an open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management...